- Healthcare IT
- Internet of Medical Things (IoMT) Market
Internet of Medical Things (IoMT) Market Size, Share, and Growth Forecast 2026 - 2033
Internet of Medical Things (IoMT) Market by Component (Software, Hardware, Services), Deployment Mode (Cloud-based, On-premises), Application (Remote Patient Monitoring, Telemedicine & Virtual Care, Chronic Disease Management, Medication Management, Clinical Operations & Workflow Management, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Home Healthcare, Long-term Care Facilities, Others), by Regional Analysis, 2026 - 2033
Internet of Medical Things (IoMT) Market Size and Trend Analysis
The global Internet of Medical Things (IoMT) market size is expected to be valued at US$ 100.9 billion in 2026 and projected to reach US$ 417.8 billion, growing at a CAGR of 22.5% between 2026 and 2033. Rapid convergence of connected medical devices, wireless sensing technology, and cloud-based analytics is the central force propelling this exceptional growth trajectory.
Healthcare systems worldwide are increasingly deploying connected monitoring devices to manage rising chronic disease burdens while easing capacity constraints on in-person clinical infrastructure. The World Health Organization has reported that noncommunicable diseases now account for a substantial majority of global deaths, intensifying demand for continuous, connected monitoring solutions that extend clinical oversight beyond traditional hospital settings.
Key Industry Highlights
- North America dominates the global Internet of Medical Things market, holding an estimated 42% share in 2026, driven by advanced healthcare infrastructure and favorable remote monitoring reimbursement policies.
- Asia Pacific is projected to register the fastest growth between 2026 and 2033, fueled by expanding healthcare infrastructure investment and government-led digital health initiatives across China and India.
- Hardware remains the dominant component segment, accounting for approximately 45% of the market in 2026, supported by continued large-scale connected sensor and device deployment.
- Software represents the fastest-growing component segment through 2033, driven by rising demand for AI-powered analytics platforms converting device data into clinical insights.
- Expanding adoption of cloud-based remote monitoring platforms presents a significant opportunity, as healthcare providers seek centralized, scalable connected care infrastructure.

Market Dynamics
Market Growth Drivers - Rising Global Burden of Chronic Diseases Driving Continuous Monitoring Demand
Escalating prevalence of chronic conditions worldwide is compelling healthcare systems to adopt connected monitoring infrastructure at scale. The World Health Organization has reported that cardiovascular disease, diabetes, and chronic respiratory conditions collectively account for the majority of global noncommunicable disease deaths, creating sustained demand for continuous, remote patient monitoring capabilities. Connected wearable sensors, implantable devices, and home-based monitoring kits enable clinicians to track vital signs and disease progression in real time, reducing hospital readmission rates and enabling earlier clinical intervention.
The Centers for Disease Control and Prevention has also highlighted rising chronic disease management costs, reinforcing healthcare provider interest in connected device ecosystems that improve care efficiency while reducing overall treatment expenditure across aging patient populations globally.
Expanding 5G Network Infrastructure Enabling Real-Time Medical Data Transmission
Accelerating global rollout of high-speed wireless network infrastructure is significantly strengthening the technical foundation supporting connected medical device ecosystems. The Federal Communications Commission has continued expanding spectrum allocation supporting next-generation wireless connectivity, enabling low-latency, high-reliability data transmission critical for real-time patient monitoring and telemedicine applications.
Enhanced network bandwidth allows hospitals and remote monitoring providers to transmit continuous physiological data streams without signal degradation, supporting more sophisticated connected diagnostic and monitoring devices. This expanding connectivity infrastructure is particularly critical for rural and underserved healthcare markets, where reliable wireless coverage extends specialist-level monitoring capabilities to previously underserved patient populations, reinforcing sustained global demand for IoMT-enabled remote care platforms.
Restraints - Cybersecurity Vulnerabilities Across Connected Medical Device Networks
Growing interconnectivity of medical devices continues to raise significant cybersecurity concerns among healthcare providers. The U.S. Food and Drug Administration has issued repeated safety communications regarding vulnerabilities identified in connected medical devices, highlighting risks of unauthorized access to sensitive patient data and potential device manipulation.
Healthcare organizations must invest substantially in network segmentation, encryption, and continuous vulnerability monitoring to safeguard connected device ecosystems, raising implementation costs. These security concerns can delay procurement decisions, particularly among smaller healthcare facilities lacking dedicated cybersecurity resources, moderating broader IoMT adoption across resource-constrained healthcare settings.
Data Privacy and Regulatory Compliance Complexities
Stringent patient data protection requirements continue to complicate IoMT deployment across multiple jurisdictions. Regulations such as the Health Insurance Portability and Accountability Act in the United States and the General Data Protection Regulation in Europe impose strict consent, storage, and cross-border data transfer requirements on connected medical device manufacturers and healthcare providers. Navigating differing regional compliance frameworks simultaneously increases development costs and extends product certification timelines, particularly for device manufacturers seeking multi-regional market access, thereby restraining faster-paced global IoMT deployment.
Opportunities - Expanding Adoption of Cloud-Based Remote Monitoring Platforms
Growing healthcare provider preference for scalable, subscription-based connected device infrastructure is opening substantial opportunity for cloud-native IoMT platform providers. Cloud-based deployment enables centralized aggregation of patient monitoring data across distributed care settings, supports predictive analytics through machine learning, and reduces the need for extensive on-site hardware investment. The Office of the National Coordinator for Health Information Technology has observed rising healthcare provider interest in cloud-hosted digital health infrastructure, reflecting broader industry migration away from siloed on-premises systems.
Vendors offering robust cloud security certifications, seamless electronic health record integration, and predictive analytics capabilities are well positioned to capture this expanding segment, particularly as hospital networks consolidate monitoring platforms across multi-facility operations to improve care coordination and reduce fragmented technology investments.
Rising Demand for Connected Chronic Disease Management Solutions
Expanding application of connected devices in chronic disease management presents a substantial growth avenue for IoMT solution providers. Healthcare systems are increasingly deploying continuous glucose monitors, connected cardiac devices, and remote respiratory monitoring tools to manage rising diabetes, cardiovascular, and chronic obstructive pulmonary disease caseloads outside traditional clinical settings.
The Centers for Medicare & Medicaid Services has expanded reimbursement coverage for remote physiologic monitoring services, creating stronger financial incentives for healthcare providers to deploy connected chronic disease management technology. Companies capable of offering integrated, condition-specific monitoring platforms with proven clinical outcome improvements stand to capture disproportionate value as reimbursement policy continues favoring connected, value-based chronic disease management models across both developed and emerging healthcare markets.
Category-wise Insights
Component Analysis
Hardware components dominate the Internet of Medical Things market, commanding an estimated 45% share in 2026. This leadership reflects continued large-scale deployment of connected sensors, wearable monitoring devices, and implantable medical devices that form the physical foundation of IoMT ecosystems across hospitals and home healthcare settings. The U.S. Food and Drug Administration has approved a growing number of connected diagnostic and monitoring devices in recent years, reinforcing sustained hardware procurement across healthcare systems.
Continuous replacement cycles, expanding wearable sensor applications, and rising demand for implantable cardiac and glucose monitoring devices further reinforce hardware segment dominance. Software, meanwhile, is registering the fastest growth rate through 2033, driven by rising demand for AI-powered analytics platforms that convert continuous device data streams into actionable clinical insights.
Deployment Mode Analysis
On-premises deployment currently leads the market, holding an estimated 58% share in 2026, largely reflecting the substantial installed base of hospital-owned monitoring infrastructure and stringent internal data-governance requirements common among large hospital networks. Many hospitals continue to favor on-premises IoMT infrastructure for perceived control over sensitive patient monitoring data and compliance with internal security protocols.
Cloud-based deployment, however, represents the fastest-growing deployment mode through 2033, driven by lower upfront infrastructure costs, faster scalability, and growing vendor investment in healthcare-specific cloud security certifications. The Healthcare Information and Management Systems Society has reported accelerating hospital interest in cloud migration strategies, particularly among mid-sized healthcare networks seeking centralized, multi-facility monitoring capabilities without extensive capital expenditure.

Regional Insights
North America Internet of Medical Things (IoMT) Market Trends and Insights
North America led the global Internet of Medical Things (IoMT) market with an estimated 41.5% share in 2026, driven by advanced healthcare IT infrastructure, widespread electronic health record adoption, and supportive reimbursement policies for remote patient monitoring. The United States accounts for nearly 90% of the regional market, supported by more than 6,000 hospitals, over 75% telehealth utilization among health systems, and continued expansion of connected care services.
The Centers for Medicare & Medicaid Services (CMS) reimbursement for Remote Physiologic Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) continues to encourage provider adoption. More than 70 million wearable health devices are estimated to be in active use across North America, while rapid deployment of AI-enabled monitoring solutions and 5G connectivity further strengthens regional market leadership.
U.S. Internet of Medical Things (IoMT) Market Size
The United States dominated the North American IoMT market in 2026, accounting for approximately 37% of the global market. The country benefits from extensive digital health infrastructure, with over 96% of non-federal hospitals using certified electronic health records and more than 4,000 hospitals offering telehealth services. CMS reimbursement policies for remote monitoring continue to accelerate adoption across chronic disease management programs.
More than 50 million Americans use connected wearable health devices, while increasing investment in AI, cloud healthcare platforms, and 5G-enabled medical connectivity supports expanding deployment of IoMT solutions across hospitals, ambulatory care centers, and home healthcare settings.
Europe Internet of Medical Things (IoMT) Market Trends and Insights
Europe accounted for an estimated 27.2% of the global IoMT market in 2026, supported by strong digital healthcare policies, universal healthcare systems, and increasing investments in connected medical technologies. More than 15,000 hospitals operate across Europe, while the European Health Data Space (EHDS) initiative promotes cross-border interoperability and secure health data exchange.
The region has one of the world's oldest populations, with approximately 21% of residents aged 65 years or older, increasing demand for remote patient monitoring and chronic disease management. Government-funded telemedicine expansion, growing deployment of connected diagnostic equipment, and increasing adoption of cloud-based healthcare platforms continue to strengthen IoMT implementation across hospitals, primary care networks, and home healthcare services.
Germany Internet of Medical Things (IoMT) Market Size
Germany represents Europe's largest IoMT market, supported by advanced healthcare infrastructure and strong digital health investments. The country operates approximately 1,900 hospitals and has one of Europe's highest healthcare expenditure levels, exceeding 12% of GDP. National digital health legislation and hospital modernization funding continue to accelerate deployment of connected medical devices, remote patient monitoring, and interoperable healthcare platforms. Germany's aging population, with more than 22% of citizens aged 65 years or older, further drives demand for IoMT-enabled chronic disease management. Continued adoption of AI-assisted diagnostics and connected hospital systems strengthens long-term market expansion.
U.K. Internet of Medical Things (IoMT) Market Size
The United Kingdom remains a significant IoMT market, supported by the National Health Service's digital transformation strategy and increasing adoption of virtual healthcare. The NHS serves approximately 67 million people, while more than 1,200 hospitals continue expanding remote patient monitoring and connected care programs.
Rising prevalence of chronic diseases and an aging population have increased demand for wearable monitoring devices and home-based healthcare solutions. Government investment in digital health infrastructure and interoperability initiatives continues to support deployment of connected medical technologies across acute care, community care, and primary healthcare settings, strengthening nationwide IoMT adoption.
France Internet of Medical Things (IoMT) Market Size
France contributes a substantial share of the European IoMT market through continued investment in digital healthcare modernization and connected medical technologies. The country operates approximately 3,000 hospitals and healthcare facilities, while healthcare expenditure represents nearly 12% of GDP. National digital health initiatives continue promoting telemedicine, interoperable electronic health records, and connected patient monitoring solutions. More than 21% of the French population is aged 65 years or older, increasing demand for remote chronic disease management and home healthcare services. Expansion of cloud-based healthcare platforms and connected diagnostic equipment continues to support nationwide IoMT market growth.
Asia Pacific Internet of Medical Things (IoMT) Market Trends and Insights
Asia Pacific accounted for approximately 22.4% of the global IoMT market in 2026 and is projected to register the fastest CAGR through 2032. The region benefits from rapid healthcare digitization, expanding hospital infrastructure, and strong government investment in digital health across China, India, Japan, South Korea, and Southeast Asia. Asia Pacific has more than 40,000 hospitals and serves over 4.7 billion people, creating substantial demand for connected healthcare technologies. Increasing smartphone penetration exceeding 75% in several major economies, expanding 5G deployment, and growing adoption of AI-enabled healthcare platforms continue to accelerate remote patient monitoring, telemedicine, and connected diagnostic systems throughout the region.
India Internet of Medical Things (IoMT) Market Size
India is one of the fastest-growing IoMT markets, supported by rapid healthcare digitalization under the Ayushman Bharat Digital Mission. The country has more than 70,000 hospitals across public and private sectors and over 1.4 billion people, creating significant demand for connected healthcare technologies. Smartphone users exceed 900 million, enabling widespread adoption of mobile health applications and remote monitoring. Expansion of telemedicine services, increasing private hospital investments, and growing prevalence of chronic diseases continue driving deployment of wearable medical devices and cloud-connected healthcare platforms across urban and semi-urban healthcare facilities.
Japan Internet of Medical Things (IoMT) Market Size
Japan maintains one of the world's most advanced IoMT markets, supported by sophisticated healthcare infrastructure and high medical technology adoption. The country operates more than 8,000 hospitals and has the world's oldest population, with nearly 30% of citizens aged 65 years or older. Rising healthcare costs and chronic disease prevalence continue driving demand for remote patient monitoring and connected healthcare solutions. Strong broadband connectivity, nationwide 5G expansion, and increasing deployment of AI-assisted healthcare technologies enable hospitals and home healthcare providers to integrate IoMT platforms for continuous patient monitoring and improved clinical outcomes.
Southeast Asia Internet of Medical Things (IoMT) Market Size
Southeast Asia is emerging as a high-growth IoMT market, supported by accelerating healthcare digitization and expanding internet connectivity across Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines. The region has a population exceeding 680 million, while smartphone penetration exceeds 75% in several countries, supporting mobile health adoption. Governments continue investing in telemedicine infrastructure and electronic health record modernization to improve healthcare accessibility. Growing private hospital expansion, increasing chronic disease burden, and rising demand for affordable remote patient monitoring solutions continue to encourage deployment of connected medical devices and cloud-based healthcare platforms across the region.

Competitive Landscape
The Internet of Medical Things market is moderately consolidated, with established medical device and healthcare technology conglomerates commanding significant share alongside specialized connected health startups. Competitive intensity centers on device interoperability, artificial intelligence-driven analytics, and cybersecurity resilience. Leading vendors continue to expand through strategic acquisitions, cloud platform partnerships, and health system collaborations to co-develop condition-specific monitoring solutions. Key differentiators include depth of interoperability certifications, predictive analytics capabilities, and long-term device reliability. An emerging trend involves subscription-based, outcome-linked pricing models gradually displacing traditional device sales structures across the connected healthcare vendor landscape.
Key Developments
- November 2025: Medtronic established its first Digital Healthcare Innovation Hub in China to accelerate the development and adoption of connected healthcare technologies and digital medical solutions. The facility was designed to support collaboration with hospitals, technology companies, and research institutions while advancing artificial intelligence, remote patient monitoring, and data-driven clinical decision support.
- September 2023: Cisco Meraki selected ORDR as its Ecosystem Partner of the Month, recognizing the company's contributions to enhancing network visibility and cybersecurity for connected devices. The recognition highlighted ORDR's integration with the Cisco Meraki platform, enabling healthcare organizations and other enterprises to automatically discover, classify, and secure Internet of Medical Things (IoMT) and IoT devices across their networks.
Companies Covered in Internet of Medical Things (IoMT) Market
- Medtronic
- GE HealthCare
- Philips
- Siemens Healthineers
- Abbott
- Boston Scientific
- Johnson & Johnson MedTech
- Cisco Systems
- Oracle Health
- Microsoft
- IBM
- Honeywell
- Cisco Meraki
- iRhythm Technologies
- Baxter International
- ResMed
- Others
Frequently Asked Questions
The global Internet of Medical Things market is valued at approximately US$ 100.9 billion in 2026, reflecting rapid healthcare adoption of connected monitoring devices and cloud-based analytics platforms.
Rising global burden of chronic diseases requiring continuous monitoring and expanding 5G network infrastructure enabling real-time medical data transmission are among the primary factors driving sustained IoMT market growth worldwide.
North America leads the market, holding an estimated 42% share in 2026, supported by advanced healthcare infrastructure and favorable remote monitoring reimbursement policies across the region.
Expanding adoption of cloud-based remote monitoring platforms and rising demand for connected chronic disease management solutions present significant growth opportunities for IoMT vendors in the coming years.
Leading companies include Medtronic, GE HealthCare, Philips, Siemens Healthineers, Abbott, Boston Scientific, and Johnson & Johnson MedTech, among others operating across the global market landscape.




